| abstract |
The present invention is directed to providing novel substituted azole compounds having GPR119 activation, particularly useful for the prevention and/or treatment of diabetes, obesity.nThe present invention relates to the provision of formula (I) (wherein each substituent in the formula is defined in detail, ring A represents an aromatic ring which may be substituted by a substituent as defined herein, and ring B represents a radical (II) Ring, R1 represents a hydrogen atom or an alkyl group, R2 represents an alkyl group or the like, ring C represents a benzene ring or a 5-6 membered aromatic heterocyclic ring, and R3 and R4 represent an alkyl group which may be substituted, etc.) An azole compound, a tautomer of the compound, or a pharmaceutically acceptable salt thereof or a mixture of these solvents.n□ □ |